Clinical Trial

Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients

Study acronym: ETERNITY
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assessed the efficacy of a combined solution of ethanol (4%) and low molecular weight heparins LMWH in preventing tunnelled dialysis catheter infection in chronic hemodialysis patients
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2017-03-13; most recent amendment 2023-12-07.
Status change: Not Yet Recruiting → Recruiting 2023-12-07
Trial Details
NCT Number NCT03083184
Lead Sponsor University Hospital, Clermont-Ferrand
Collaborators: Ministry of Health, France, CH du Puy en Velay, Hôpital Emile Roux, University Hospital, Toulouse, Centre hospitalier de Chambéry, Calydial, Hôpital Edouard Herriot, Nouvel Hôpital Civil, 1 place de l'Hôpital 67091 Strasbourg cedex, Hôpital Lapeyronie, Centre de dialyse d'Alès, University Hospital of Saint-Etienne, Perpignan Hospital Center, POLYCLINIQUE SAINT-ROCH, CHU Hôpital Maison Blanche, 45 Rue Cognacq-Jay 51092 REIMS Cedex
Conditions Tunnelled Hemodialysis Catheter Infection
Enrollment 400 participants
Start Date 2018-02-09
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2023-12-08